Sarepta Therapeutics Statistics

Total Valuation

BMV:SRPT has a market cap or net worth of MXN 39.84 billion. The enterprise value is 50.39 billion.

Market Cap	39.84B
Enterprise Value	50.39B

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	97.71M
Shares Outstanding	n/a
Shares Change (YoY)	-0.99%
Shares Change (QoQ)	+9.51%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	88.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	11.24
PS Ratio	0.85
PB Ratio	1.56
P/TBV Ratio	1.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.69, with an EV/FCF ratio of -5.92.

EV / Earnings	-46.11
EV / Sales	1.09
EV / EBITDA	16.69
EV / EBIT	n/a
EV / FCF	-5.92

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 1.01.

Current Ratio	2.89
Quick Ratio	1.53
Debt / Equity	1.01
Debt / EBITDA	8.45
Debt / FCF	-3.02
Interest Coverage	-0.05

Financial Efficiency

Return on equity (ROE) is -4.76% and return on invested capital (ROIC) is -0.02%.

Return on Equity (ROE)	-4.76%
Return on Assets (ROA)	-0.02%
Return on Invested Capital (ROIC)	-0.02%
Return on Capital Employed (ROCE)	-0.03%
Revenue Per Employee	34.11M
Profits Per Employee	-796,608
Employee Count	1,372
Asset Turnover	0.70
Inventory Turnover	2.59

Taxes

In the past 12 months, BMV:SRPT has paid 637.88 million in taxes.

Income Tax	637.88M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	398.47
200-Day Moving Average	n/a
Relative Strength Index (RSI)	60.94
Average Volume (20 Days)	475

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.81

Income Statement

In the last 12 months, BMV:SRPT had revenue of MXN 46.80 billion and -1.09 billion in losses. Loss per share was -11.29.

Revenue	46.80B
Gross Profit	10.66B
Operating Income	-17.58M
Pretax Income	-455.07M
Net Income	-1.09B
EBITDA	757.10M
EBIT	-17.58M
Loss Per Share	-11.29

Full Income Statement

Balance Sheet

The company has 15.09 billion in cash and 25.73 billion in debt, giving a net cash position of -10.64 billion.

Cash & Cash Equivalents	15.09B
Total Debt	25.73B
Net Cash	-10.64B
Net Cash Per Share	n/a
Equity (Book Value)	25.60B
Book Value Per Share	261.99
Working Capital	32.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.67 billion and capital expenditures -2.84 billion, giving a free cash flow of -8.52 billion.

Operating Cash Flow	-5.67B
Capital Expenditures	-2.84B
Free Cash Flow	-8.52B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.77%, with operating and profit margins of -0.04% and -2.34%.

Gross Margin	22.77%
Operating Margin	-0.04%
Pretax Margin	-0.97%
Profit Margin	-2.34%
EBITDA Margin	1.62%
EBIT Margin	-0.04%
FCF Margin	n/a

Dividends & Yields

BMV:SRPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.99%
Shareholder Yield	n/a
Earnings Yield	-2.74%
FCF Yield	-21.37%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:SRPT has an Altman Z-Score of 2.08 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.08
Piotroski F-Score	1